SELVAS Healthcare, Inc. (KOSDAQ:208370)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,450.00
-30.00 (-0.67%)
At close: Mar 6, 2026
-1.55%
Market Cap 109.17B
Revenue (ttm) 29.79B
Net Income (ttm) 2.34B
Shares Out 25.72M
EPS (ttm) 90.55
PE Ratio 46.88
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 216,709
Average Volume 753,792
Open 4,375.00
Previous Close 4,480.00
Day's Range 4,315.00 - 4,595.00
52-Week Range 3,405.00 - 7,490.00
Beta -1.07
RSI 36.59
Earnings Date Mar 19, 2026

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss cent... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1993
Employees 128
Stock Exchange KOSDAQ
Ticker Symbol 208370
Full Company Profile

Financial Performance

In 2024, SELVAS Healthcare's revenue was 31.70 billion, an increase of 6.34% compared to the previous year's 29.81 billion. Earnings were 3.15 billion, a decrease of -39.03%.

Financial Statements

News

There is no news available yet.